Caliper In the News
CALIPER LIFE SCIENCES' PRESENTATION AT SUSQUEHANNA FINANCIAL GROUP EMERGING TRENDS CONFERENCE TO BE WEBCAST
October 24, 2006
HOPKINTON, Mass., Oct. 24 /PRNewswire-FirstCall/ – Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced that its presentation at the Susquehanna Financial Group Emerging Trends Conference will be webcast on Wednesday, November 1, 2006, at 1:30 p.m. EST. Kevin Hrusovsky, President and CEO of Caliper, will be presenting. The live webcast can be accessed at http://www.wsw.com/webcast/sig3/calp/ . An archived presentation will be available through January 29, 2007.
About Caliper Life Sciences
Caliper Life Sciences is a leading provider of drug discovery and life sciences research solutions for the pharmaceutical and biotechnology industries. With its recent acquisitions of NovaScreen Biosciences and Xenogen Corporation, Caliper has positioned itself to transform drug discovery and development through a keen focus on clinically relevant experimentation. Caliper's products and services, assembled from a leading portfolio of microfluidics, liquid handling, and imaging technologies, span in vitro and in vivo experimentation and address key issues on the critical path of drug discovery and development. More information about Caliper can be found at www.caliperLS.com .
SOURCE Caliper Life Sciences, Inc. -0- 10/24/2006 /CONTACT: Michele Boudreau of Caliper Life Sciences, +1-650-279-2088/ /Web site: http://www.caliperLS.com/ (CALP) CO: Caliper Life Sciences, Inc. ST: Massachusetts IN: BIO HEA MTC SU: TDS CCA GM-TH -- SFTU174 -- 8068 10/24/2006 18:46 EDT http://www.prnewswire.com
